The company may no longer be operating, as it has been acquired. Find out why through their latest events.
La Jolla Pharmaceutical Future Growth
Future criteria checks 4/6
La Jolla Pharmaceutical is forecast to grow earnings and revenue by 59% and 19.8% per annum respectively while EPS is expected to grow by 55.8% per annum.
NasdaqCM:LJPC - Analysts future estimates and past financials data (USD Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
12/31/2024
77
16
N/A
N/A
1
12/31/2023
64
8
N/A
N/A
1
12/31/2022
47
1
N/A
N/A
1
6/30/2022
46
4
13
13
N/A
3/31/2022
52
5
14
14
N/A
12/31/2021
76
20
28
28
N/A
9/30/2021
74
12
18
18
N/A
6/30/2021
70
3
7
7
N/A
3/31/2021
60
-16
-8
-8
N/A
12/31/2020
33
-39
-38
-38
N/A
9/30/2020
30
-61
-48
-47
N/A
6/30/2020
26
-79
-57
-56
N/A
3/31/2020
26
-93
-65
-65
N/A
12/31/2019
23
-117
-86
-85
N/A
9/30/2019
20
-137
-101
-100
N/A
6/30/2019
18
-158
-119
-118
N/A
3/31/2019
14
-181
-141
-139
N/A
12/31/2018
10
-199
-155
-152
N/A
9/30/2018
6
-193
-153
-146
N/A
6/30/2018
2
-168
-136
-127
N/A
3/31/2018
1
-142
-118
-109
N/A
12/31/2017
N/A
-115
-94
-85
N/A
9/30/2017
0
-101
-83
-78
N/A
6/30/2017
0
-96
-78
-75
N/A
3/31/2017
0
-85
-70
-68
N/A
12/31/2016
1
-78
-61
-59
N/A
9/30/2016
1
-65
-50
-49
N/A
6/30/2016
2
-54
-40
-39
N/A
3/31/2016
1
-49
N/A
-33
N/A
12/31/2015
1
-42
N/A
-25
N/A
9/30/2015
1
-37
N/A
-22
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LJPC's forecast earnings growth (59% per year) is above the savings rate (1.9%).
Earnings vs Market: LJPC's earnings (59% per year) are forecast to grow faster than the US market (14.9% per year).
High Growth Earnings: LJPC's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: LJPC's revenue (19.8% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: LJPC's revenue (19.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if LJPC's Return on Equity is forecast to be high in 3 years time
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2022/08/22 09:06
End of Day Share Price
2022/08/19 00:00
Earnings
2022/06/30
Annual Earnings
2021/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
La Jolla Pharmaceutical Company is covered by 11 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.